Rutgers Health researchers and others find hundreds of young patients receive potentially dangerous medication combinations, raising concerns about prescription practice.
Kleinman noted, "Because of this risk, the FDA has warned that ziprasidone should not be prescribed with other drugs that have demonstrated QT prolongations." About 32 percent (364) of the 1,121 ...